Inhibitor Therapeutics, Inc. (INTI)
OTCMKTS · Delayed Price · Currency is USD
0.0740
0.00 (0.00%)
Apr 15, 2026, 4:00 PM EST
Inhibitor Therapeutics Employees
As of December 31, 2025, Inhibitor Therapeutics had 8 total employees, including 2 full-time and 6 part-time employees. The number of employees decreased by 1 or -11.11% compared to the previous year.
Employees
8
Change (1Y)
-1
Growth (1Y)
-11.11%
Revenue / Employee
n/a
Profits / Employee
-$660,067
Market Cap
12.77M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 8 | -1 | -11.11% | 2 | 6 |
| Dec 31, 2024 | 9 | 0 | - | 3 | 6 |
| Dec 31, 2023 | 9 | 3 | 50.00% | 3 | 6 |
| Dec 31, 2022 | 6 | 4 | 200.00% | 3 | 3 |
| Dec 31, 2021 | 2 | 0 | - | 1 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| HOOKIPA Pharma | 87 |
| Oncotelic Therapeutics | 26 |
| Brainstorm Cell Therapeutics | 23 |
| Zeo ScientifiX | 20 |
| ZIVO Bioscience | 7 |
| Provectus Biopharmaceuticals | 6 |
| Anebulo Pharmaceuticals | 3 |
Inhibitor Therapeutics News
- 15 days ago - Inhibitor Therapeutics Provides Clinical, Formulation and IP Update on Itraconazole Program for Gorlin Syndrome - GlobeNewsWire
- 1 year ago - Complement Inhibitor Therapeutics Pipeline Developments Research Report 2024 - GlobeNewsWire
- 1 year ago - Complement Inhibitors Clinical Trial Pipeline Analysis: 40+ Key Companies Shaping the Future of Complement Inhibitor Therapeutics | DelveInsight - GlobeNewsWire
- 1 year ago - Inhibitor Therapeutics, Inc. Provides Update on its Clinical Development Plan - GlobeNewsWire
- 2 years ago - Introducing Inhibitor Therapeutics, Inc. New Scientific Advisory Board - PRNewsWire
- 2 years ago - Inhibitor Therapeutics, Inc. Exclusive License with Johns Hopkins University - PRNewsWire